medigraphic.com
ISSN 1561-2961 (Print)

2019, Number 3

<< Back Next >>

Rev Cuba Enf 2019; 35 (3)

Hypoglycemia and associated risk factors during continuous insulin administration in critically-ill patients

de Azeredo GRM, Vianna AK, Chaves SSP

Language: Portugués
References: 28
Page: 1-17
PDF size: 205.74 Kb.


ABSTRACT

Introduction: Hypoglycemia is the most important adverse effect in patients undergoing intravenous insulin therapy in the intensive care unit, due to its difficult control by health professionals, also being associated with other clinical and pathological risk factors.
Objective: To identify in the literature the risk factors for hypoglycemia during the continuous administration of intravenous insulin.
Methods: Integrative review study of the literature. Data collection was carried out by accessing the databases belonging to the Virtual Health Library (VHL), LILACS, MEDLINE, BDENF, and PUBMED, during the period from March to April 2017, which resulted in the selection of 11 studies after the review process.
Conclusion: Risk factors for hypoglycemia during continuous insulin infusion are rigorous glycemic objective, inadequate or discontinued nutritional support, diabetes, organic failure, acute and chronic renal failure, hemodialysis, lack of standardization of the blood glucose measurement pathway, sepsis, vasoactive drugs, delays in blood glucose measurements, inadequate adjustments in the venous insulin protocol, 2-4h insulin verification intervals, influence of glycosylated hemoglobin (HbA1c), liver disease, and difficulties in application and continuity of glycemic surveillance protocols and infusions. Thus, professionals who are directly involved with the aforementioned therapy and with the care for the assisted patient can define behaviors that minimize the occurrence of hypoglycemia and deaths.


REFERENCES

  1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002 [acesso: 16/03/2017];87(3):978-82. Disponible en: https://doi.org/ 10.1210/jcem.87.3.8341

  2. Pasquel FJ, Umpierrez GE. Manejo de lahiperglucemia em el paciente hospitalizado. Medicina (B. Aires). 2010 [acesso: 17/07/2017];70(3):275-83. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000300014&lng=es

  3. Lazzari CM, Volkart T. Eficiência da solução de insulina: comparação entre diferentes tempos de manutenção da solução. Rev. bras. ter. intensiva. 2010 [acesso: 19/07/2017];22(4):358-62. Disponible en: http://www.scielo.br/pdf/rbti/v22n4/08.pdf

  4. Van DBG, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001 [acesso: 08/06/2017];345(19):1359-67. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/ 11794168

  5. Van dBG, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006 [acesso: 20/01/2017];354(5):449-61. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/16452557

  6. Silva WO. Controle glicêmico em pacientes críticos na UTI. Revista Hospital Universitário Pedro Ernesto. 2013 [acesso: 20/01/2016];12(3):47-56. Disponible en: http://revista.hupe.uerj.br/detalhe_artigo.asp?id = 419

  7. Egi M, Bello R, Stachawski E, French CJ, Hart G, Stow P, et al. Intensive insulin therapy in postoperative intensive care unit patients: a decision analysis. Am J Respir Crit Care Med. 2006 [acesso: 10/02/2016];173(4):407-13. Disponible en: https://www.ncbi.nlm.nih.gov/ pubmed/16239623

  8. Sociedade Brasileira de Diabetes (SBD). Controle da Glicemia em paciente hospitalizado. Posicionamento Oficial SBD nº 03/2015. São Paulo (SP): SBD; 2015.

  9. Gomes MP, Foss CM, Foss-Freitas MC. Controle da Hiperglicemia intra-hospitalar em pacientes Críticos e não-críticos. Medicina (Ribeirão Preto). 2014 [acesso: 16/05/2016];47(2):194-200. Disponible en: http://revista.fmrp.usp.br/2014/vol47n2/ DMT_Controle-da-hiperglicemia-intra-hospitalar-em-pacientes-criticos-e-nao-criticos.pdf

  10. Paixão CT, Silva LD, Nepuceno RM, Andrade KBS, Almeida LF. Controle Glicêmico em pacientes críticos que recebem insulina: revisão integrativa. Rev. pesqui. cuid. fundam. 2015 [acesso: 27/07/2017];7(4):3339-50. Disponible en: http://www.seer.unirio.br/ index.php/cuidadofundamental/article/view/4139

  11. Stewart K, Bonito CG, Tomlinson H, Thomas FL, Homlok J, Noémi SN, et al. Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis. Ann Intensive Care. 2016 [acesso: 10/03/2017];6:24. Disponible en: https://www.ncbi. nlm.nih.gov/pmc/articles/PMC4811843/pdf/13613_2016_Article_125.pdf

  12. Corrêa TD, Almeida FP, Cavalcanti AB, Pereira AJ, Silva E. Avaliação da percepção de enfermeiros sobre três protocolos para controle glicêmico em pacientes críticos. Einstein (São Paulo). 2012 [acesso: 10/03/2017];10(3):347-53. Disponible en: http://www.scielo.br/ pdf/ eins/v10n3/v10n3a16

  13. Boutin JM, Gauthier L. Insulin infusion therapy in critically ill patients. Can J Diabetes. 2014 [acesso: 18/04/2017];38(2):144-50. Disponible en: https://www.ncbi.nlm.nih.gov/ pubmed/24690510

  14. Botelho LLR, Cunha CCA, Macedo M. O método de revisão integrativa nos estudos organizacionais. Gestão e Sociedade. 2011 [acesso: 12/05/2017];5(11):121-36. Disponible en: https://www.gestaoesociedade.org/gestaoesociedade/article/view/1220/906

  15. Santos CMC, Pimenta CAM, Nobre MRC. A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Latino-Am Enfermagem. 2007 [acesso: 12/07/2017];15(3):508-11. Disponible en: http://dx.doi.org/10.1590/S0104-116920070003000

  16. Souza MT, Silva MD, Carvalho R. Revisão integrativa: o que é e como fazer. Einstein (São Paulo). 2010 [acesso: 15/05/2017];8(1):102-6. Disponible en: http://www.scielo.br/ scielo.php?pid = S1679-45082010000100102

  17. Pompeo DA, Rossi LA, Galvão CM. Revisão integrativa:etapa inicial do processo de validação de diagnóstico de enfermagem. Acta Paul Enferm. 2009 [acesso: 13/05/2017];22(4):434. Disponible en: http://dx.doi.org/10.1590/S0103-21002009000400014

  18. Bilotta F, Rosa G. Glycemia management in critical care patients. Word Journal of Diabetes. 2012 [acesso: 20/04/2017];3(7):130-4. Disponible en: www.ncbi.nlm.nih.gov/ pm/articles/PMC3399911/

  19. Perez ME, Varga LI, Rose C, Gaughan JP. Comparison of the efficacy and safety of two different insulin infusion protocols in the medical intensive care unit. Hosp Pharm. 2013 [acesso: 20/04/2017];48(3):213-8. Disponible en: www.ncbi.nlm.nih.gov/pm/articles/ PMC3839516/

  20. Honiden S, Inzucchi SI. Metabolic management during critical illness: glycemic control in the ICU. Semin Respir Crit Care Med. 2015 [acesso: 16/03/2017];36(06):859-69. Disponible en: www.thieme-connect.de/products/ejournals/html/10.1055/s-0035-1565243

  21. Paixão CT, Nepomuceno RM, Santos MM, Silva LD. Fatores predisponentes para hipoglicemia: aumentando a segurança do paciente crítico. Revenferm UERJ. 2015 [acesso: 16/03/2017];23(1):70-5. Disponible en: http://www.e-publicacoes.uerj.br/index.php/ enfermagemuerj/article/view/15098/12331

  22. Mahmoodpoor A, Hamishhkar H, Beigmohammadi M, Sarvin S, Shadvar K, Soleimanpour H, Rahimi A, Safari S. Predisposing factores for hypoglycemia and its relation with mortality in criticallyill patients undergoing insulin therapy in intensive care unit. Anesth Pain Med. 2016 [acesso: 20/04/2017];6(1):e33849. Disponible en: www.ncbi.nlm.nih..gov/pmc/articles/PMC4835586/

  23. Marvin MR, Inzucchi SE, Besterman BJ. Minimization of hypoglycemia as an adverse event during insulin infusion: further refinement of the Yale protocol. Diabetes Technol Ther. 2016 [acesso: 20/04/2017];18(8):480-6. Disponible en: www.ncbi.nlm.nih.gov/ pmc/articles/PMC4991569/

  24. Marvin MR, Inzucchi SE, Besterman BJ. Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin. Diabetes Technol Ther. 2013 [acesso: 16/03/2017];15(3):246-52. Disponible en: www.ncbi.nlm.nih.gov/pm/articles/PMC3696925/?tool = pubmed

  25. Paixão CT, Silva LD, Doerzapff PB, Granadeiro RMA, Farias RLA, Santos SS. Fatores de risco para hipoglicemia em pacientes críticos que usam infusão contínua de insulina endovenosa na unidade de terapia intensiva.ABCS Health Sci. 2014 [acesso: 16/03/2017];39(3):194-8. Disponible en: www.portalnepas.org.br/abcshs/article/viewFile/ 655/654

  26. Sandler V, Misiasz MR, Jones J, Baldwin D. Reducing the risk of hypoglycemia associated with intravenous insulin: experience with a computerized insulin infusion program in 4 adult intensive care units. J Diabetes Sci Technol. 2014 [acesso: 20/04/2017];8(5):923-9. Disponible en: www.ncbi.nlm.nih.gov/pm/articles/PMC4455385/

  27. Torreda MR, Serrano CdL, Solsona DA, Ibars RMC, Arfelis JMN. Control Glucémico em el enfermo crítico: comparación de dos protocolos de insulinización intravenosa. Clin Med. 2014 [acesso: 16/03/2017];142(5):192-99. Disponible en: www.ncbi.nlm.nih.gov/ pmc/articles/PMC4455385/

  28. Kauffmann RM, Hayes RM, Vanlaeken AH, Norris PR, Diaz JJ, Maio AK, Collier Bryan. Hypocaloric enteral nutrition protects against hypoglycemia associated with intensive insulin therapy better than intravenous dextrose. Am Surg. 2014 [acesso: 16/03/2017];80(11):1106-11. Disponible en: www.ncbi.nlm.nih.gov/pmc/articles/ PMC4447628/?tool=pubmed




2020     |     www.medigraphic.com